Accuray President and Chief Executive Officer Suzanne Winter Returns from Medical Leave of Absence

Rhea-AI Summary

Accuray Incorporated (NASDAQ: ARAY) announced that Suzanne Winter has returned from her temporary medical leave and resumed her full duties as President and Chief Executive Officer, effective October 15, 2024. Sandeep Chalke, who served as interim CEO during Winter's absence, will continue in his role as Senior Vice President and Chief Commercial Officer.

Joseph Whitters, Chairman of the Board at Accuray, expressed delight at Winter's return and appreciation for Chalke's leadership during her absence. Accuray, headquartered in Madison, Wisconsin, is committed to expanding the potential of radiation therapy in oncology and neuro-radiosurgery, focusing on innovative solutions for complex and common cases alike.

Positive

• CEO Suzanne Winter has returned from medical leave, resuming full duties
• Continuity in leadership with Sandeep Chalke returning to his previous role

Negative

• None.

MADISON, Wis., Oct. 15, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced that, effective as of today, Suzanne Winter has returned from her temporary medical leave and assumed her full duties as President and Chief Executive Officer. Sandeep Chalke, who has served as interim CEO during Ms. Winter's absence, will continue in his position as Senior Vice President and Chief Commercial Officer.

"On behalf of the entire Board of Directors, I am delighted Suzanne has resumed her role as CEO. We appreciate the leadership provided by Sandeep in her absence and the support of the global Accuray team," said Joseph Whitters, Chairman of the Board at Accuray.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-president-and-chief-executive-officer-suzanne-winter-returns-from-medical-leave-of-absence-302276241.html

SOURCE Accuray Incorporated

FAQ

When did Suzanne Winter return as CEO of Accuray (ARAY)?

Suzanne Winter returned as President and CEO of Accuray (ARAY) on October 15, 2024, after a temporary medical leave of absence.

Who served as interim CEO of Accuray (ARAY) during Suzanne Winter's absence?

Sandeep Chalke served as interim CEO of Accuray (ARAY) during Suzanne Winter's temporary medical leave of absence.

What is Accuray's (ARAY) primary focus in the medical field?

Accuray (ARAY) focuses on expanding the potential of radiation therapy in oncology and neuro-radiosurgery, developing innovative solutions for complex and common treatment cases.

Where is Accuray (ARAY) headquartered?

Accuray (ARAY) is headquartered in Madison, Wisconsin, with facilities worldwide.